Macrophage-mediated
diseases indications

Allocetra™ pipeline building momentum:
strong phase 2 progress with next steps in sight

Indication:

Pre-clinical

Phase I/II

Phase II

Phase III

ENX-CL-05-002

Primary knee osteoarthritis

Administration:

Local knee injection

ClinicalTrials.gov ID

NCT07580716

A multicenter, randomized, double-blind, placebo-controlled, Phase IIb study to evaluate intra-articular (IA) injections of Allocetra in participants with moderate-to-severe age related symptomatic primary knee osteoarthritis (OA).

View program

ENX-CL-05-001

Moderate knee osteoarthritis

Administration:

Local knee injection

ClinicalTrials.gov ID

NCT06233474

A double blind, randomized, multi-center study to evaluate the safety and efficacy of intra-articular administration of Allocetra™ compared to placebo in patients with symptomatic knee osteoarthritis.

View program

1400-24-SMC

Temporomandibular joint osteoarthritis

Administration:

Local TMJ injection

ClinicalTrials.gov ID

NCT06748651

A single center, Investigator-initiated study to evaluate the safety and initial efficacy of intra-articular administration of Allocetra™ to patients with Temporomandibular Joint Osteoarthritis (TMJ-OA).

View program